Loyola University

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Loyola University sits in the top decile of US sponsors by registered trial count (#256 of 15,742 sponsors by registered trial count).

92 total trials 12 currently recruiting 59 completed top decile by trial count

Loyola University: 92 sponsored US clinical trials, 12 recruiting.

Loyola University sponsors 92 registered US clinical trials on ClinicalTrials.gov, 12 of them currently recruiting, and 59 completed. 25 of these trials are in Phase 3-4 (later-stage) and 22 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Diabetes, with 3 trials.

Top-decile sponsor footprint

Loyola University ranks in the top decile of sponsors by registered trial count (#256 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 41/100

59 of 73 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

92 total, page 1 of 2

RECRUITING NA

Multisensory Early Oral Administration of Human Milk (M-MILK) for Very Preterm Infants

NCT07216664

RECRUITING Phase 3

RCT Glargine vs NPH for Treatment of DM in Pregnancy

NCT06619301

RECRUITING Phase 2

Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer

NCT05983276

RECRUITING NA

The Impact of a Race-Based Stress Reduction Intervention

NCT05902741

RECRUITING Phase 4

IPACK on Early Pain Scores After ACL Reconstruction

NCT05985629

RECRUITING Phase 2

Immunogenicity of Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients

NCT05554068

RECRUITING Phase 4

Buprenorphine, Clonidine, and Dexamethasone on Duration of Brachial Plexus Blocks for Upper Extremity Surgery

NCT05824832

RECRUITING

Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for Patients With Clinically Localized Renal Tumors

NCT05728957

RECRUITING

Musculoskeletal and Pelvic Floor Health in Female Chronic Overlapping Pelvic Pain Conditions

NCT05750212

RECRUITING Phase 4

Urinary Microbiome Changes Following Administration of 500 mg of NDS-446 in Women With Dry OAB at 12 Weeks

NCT05557279

RECRUITING Phase 4

Ketamine as a Supplement to Local Anesthesia for Minor Procedures

NCT06284473

RECRUITING Phase 1

Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

NCT02870244

ACTIVE NOT RECRUITING NA

Effect of Standardization of Urine Collection Using PEEZY Device as Compared to Clean Peezy for DAB

NCT05554081

ACTIVE NOT RECRUITING Phase 1

CD19 Chimeric Antigen Receptor (CAR) T Cells for Adults With Recurrent or Refractory B Cell Malignancies

NCT04214886

ACTIVE NOT RECRUITING

Gut Microbiota, Short Chain Fatty Acids, and Adiposity Across The Epidemiological Transition

NCT03378765

ACTIVE NOT RECRUITING NA

Focal Salvage HDR Brachytherapy for Locally Recurrent Prostate Cancer in Patients Treated With Prior Radiotherapy

NCT03312972

ACTIVE NOT RECRUITING Phase 1

Transfer of Genetically Engineered Lymphocytes in Melanoma Patients

NCT01586403

NOT YET RECRUITING NA

Utilizing Electronic Modules to Educate on Sexual Health Practices During Pregnancy

NCT07497971

NOT YET RECRUITING NA

Effects of Core Strengthening Exercises for Treating TMD

NCT07226505

COMPLETED NA

Surgeon Core-strengthening Program as a Modifier for Exertion Associated With Vaginal Surgery

NCT06525701

COMPLETED NA

Bridging the Health Disparities Gap in Decision-Making Among Limited English Proficient (LEP) Patients With Pelvic Floor Disorders

NCT05871268

COMPLETED NA

Multisensory Early Oral Administration of Human Milk in Preterm Infants

NCT06230848

COMPLETED NA

Physician Awareness of Patients' Preferred Level of Involvement in Decision Making

NCT05314959

COMPLETED NA

Mindfulness for African Americans Postpartum

NCT05280938

COMPLETED NA

Restoring the Anatomic Tension Relationship of the Long Head of the Biceps During Tenodesis

NCT06571695

COMPLETED NA

Intraoperative Cone-beam CT for Percutaneous Nephrolithotomy

NCT04556396

COMPLETED NA

Anxiety Reduction During Office Procedural Medicine Using Aromatherapy

NCT04260399

COMPLETED NA

Photographic Evidence on Total Knee Arthroplasty Outcomes

NCT07223359

COMPLETED NA

The Efficacy of Cryotherapy in Pregnancy Related Pelvic Girdle Pain

NCT04469192

COMPLETED NA

Enhanced Consent and Preparedness for Surgery Trial

NCT03988569

COMPLETED Phase 4

Sub-dissociative Dose Ketamine Dosing Study

NCT03714620

COMPLETED NA

Effect of Compression Stockings on Cerebral Desaturation Events in Obese Patients Undergoing Shoulder Arthroscopy in the Beach Chair

NCT03996668

COMPLETED NA

Music Listening on Preoperative Anxiety in Female Pelvic Medicine and Reconstructive Surgery

NCT03651310

COMPLETED Phase 2

Blood Pressure in Blacks and Calcium (BBC) and Vitamin D Study

NCT03070483

TERMINATED Phase 1

HDR Brachytherapy, EBRT and STAD for the Treatment of Prostate Cancer

NCT03553602

COMPLETED NA

Predictive Value of the Active Straight Leg Raise on the Efficacy of a SJB in Posterior PGP During Pregnancy

NCT03518840

COMPLETED NA

BCAA Supplemental Study

NCT03339232

TERMINATED Phase 4

The Use of Oral Naloxone to Prevent Post Spinal Fusion Ileus

NCT03176316

TERMINATED Phase 4

Ideal Time of Oxytocin Infusion During Cesarean Section

NCT03246919

COMPLETED NA

Probiotics Effect on the Female Urinary Microbiome ProFUM Trial (Probiotics Effect on the Female Urinary Microbiome)

NCT03250208

COMPLETED NA

RiSE to Prevent Cardiovascular Disease in African Americans

NCT03878290

COMPLETED NA

The Role of Antimicrobial Foam Dressing in Prevention of Cesarean Section Wound Complications

NCT03136159

COMPLETED NA

Expanded Quantitative Urinary Culture (EQUC) vs Standard Culture (SUC) Techniques in the Clinical Care

NCT03190421

COMPLETED NA

The Feasibility of a Web-based Application to Monitor Home Blood Pressure

NCT03116815

TERMINATED Phase 2

Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide

NCT03088709

COMPLETED Phase 4

Investigation of the Effect of the Female Urinary Microbiome on Incontinence

NCT02835846

TERMINATED Phase 4

Intra-articular Local Anesthetic Injection and Hematoma Aspiration

NCT02951884

COMPLETED

Bladder Environment: Microbiome Oxygen Relationship

NCT02868463

COMPLETED

Host Response to Pessaries in Microbial Communities of the Postmenopausal Vagina

NCT02605135

COMPLETED NA

The Estrogen Impact on Overactive Bladder Syndrome: Female Pelvic Floor Microbiomes and Antimicrobial Peptides

NCT02524769

Page 1 of 2 Next →

What is open in the Loyola University pipeline

12 recruiting of 92 indexed (13% open); 59 completed (64%).

Phase mix: 25 late (III/IV) vs 22 early (I/II) (balanced across stages).

Top condition: Diabetes (3 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Loyola University: open-pipeline peers nationwide

Peers matched on 92 registered trials and 13% open enrollment, not the therapeutic-area sidebar.

Loyola University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 020406080100 10%20%30%40% Total trials Recruiting share Loyola UniversityChildren's National Research InstituteDrexel UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)National Institute on Alcohol Abuse and Alcoholism (NIAAA)Food and Drug Administration (FDA)VA Greater Los Angeles Healthcare SystemIntermountain Health CareMetroHealth Medical Center
Loyola University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Loyola University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 92 trials (± recruiting share)

Sponsors near 13% open enrollment (± trial volume)

What to do with this Loyola University page

92 registered trials is a research-attention snapshot, not an endorsement of Loyola University or any single study.

  • 12 of Loyola University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Diabetes is the condition Loyola University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Diabetes trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Loyola University pipeline card: 92 registered trials from official public datasets.Report a data error.